申请人:Liang Congxin
公开号:US20100144768A1
公开(公告)日:2010-06-10
Pyrimidinone derivatives have enhanced and unexpected drug properties as inhibitors of protein kinases and are useful in treating disorders related to abnormal protein kinase activities such as inflammatory diseases and certain types of cancer.